Dermatology· Topic 3.3 Vascular dermatoses· 3.3.2

Erythema nodosum

Erythema nodosum is a delayed hypersensitivity panniculitis presenting as symmetric, tender, erythematous subcutaneous nodules on the anterior shins, most commonly following streptococcal pharyngitis but also linked to sarcoidosis, inflammatory bowel disease, Coccidioides, Yersinia, pregnancy, and drugs such as oral contraceptives. Diagnosis is clinical, and management is directed at the underlying cause with NSAIDs, bed rest, and cool compresses for symptom control.

9 min read1 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: erythema nodosum (EN) is a delayed hypersensitivity reaction causing panniculitis, inflammation of the subcutaneous fat, that presents as tender, erythematous nodules.

  • Epidemiology

    Sex distribution: more common in women, and often presents with associated joint pain.

  • Risk factors

    Recent streptococcal infection: the leading identifiable antecedent.

  • Pathophysiology

    Delayed (type IV) hypersensitivity reaction: immune complexes and a delayed cell-mediated response localize to the subcutaneous fat rather than the epidermis.

  • Clinical features

    Diagnostic nodules: tender, erythematous, subcutaneous nodules about the size of a quarter, most commonly on the anterior lower legs, bilateral and symmetric.

  • Differential diagnosis

    Cellulitis: unilateral, warm, poorly demarcated erythema without the bilateral symmetric nodular pattern of EN, and typically progresses over days rather than presenting as fixed nodules.

  • Diagnosis

    Clinical diagnosis from the classic presentation: bilateral, tender, erythematous nodules confined to the anterior shins in a patient with a compatible history establishes the diagnosis; biopsy is…

  • Management

    First, identify and treat the underlying cause: address the trigger directly (treat streptococcal pharyngitis, discontinue an implicated drug, or manage sarcoidosis or inflammatory bowel disease)…

  • Complications

    Persistent or recurrent nodules: can occur if the underlying trigger (for example ongoing oral contraceptive use or unrecognized inflammatory bowel disease) is not addressed.

  • Prognosis

    Favorable in most cases: EN is typically self-limited and resolves without scarring or ulceration once the trigger resolves or is treated.

  • Prevention

    Address modifiable triggers: discontinuing an implicated oral contraceptive or sulfonamide drug reduces the chance of recurrence.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.